Tests anal function in people with inflammatory bowel disease
Part of Digestive system clinical trials.
This study checks how well the anal area works in people with inflammatory bowel disease (IBD), even when your bowel disease is “in remission” but you may still have symptoms. It may help doctors better understand the cause of ongoing problems and guide future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are either a healthy volunteer or have IBD (Crohn’s or ulcerative colitis)
- If you have IBD, your disease must be in remission (not “active disease”)
- You must be at least partly experiencing ongoing symptoms, or be symptom-free but still have IBD in remission
- No recent anal or pelvic surgery (including procedures around childbirth)
- No major ongoing health problems like uncontrolled diabetes, heart disease, kidney disease, or liver disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares the bacteria and natural chemicals in the intestines of people with irritable bowel syndrome (IBS) to those without it. It aims to find differences that could help improve IBS diagnosis or treatment.
This study tests a device called AIRE-2 that analyzes your breath to see if it can help manage IBD symptoms. It is for people with IBD who are in remission but still have IBS-like symptoms like belly pain or bloating.
This study looks for signs in your body—like breath and blood tests—that can show how well you are following a special diet for IBS. It aims to find better ways to track diet compliance, which could help make dietary treatments more effective.
This trial tests a new treatment called SMT04 for people with irritable bowel syndrome (IBS), specifically the diarrhea or mixed types. It may help reduce symptoms like abdominal pain and changes in bowel habits.
This study checks biomarkers (signals in blood and/or stool) in adults with moderate-to-severe ulcerative colitis. It compares patients starting targeted medicines and looks for marker patterns that may reflect how the disease is behaving.
This study checks how sensitive your gut is to normal stimuli in people with IBS, ulcerative colitis, Crohn’s disease, and in healthy volunteers. Results may help researchers understand why some people feel more abdominal discomfort and how that connects to inflammatory bowel conditions.
Hear when a new Irritable Bowel Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.